•
Mar 31

Ovid Therapeutics Q1 2025 Earnings Report

Expected Revenue:$33.3K
-44.5% YoY
Expected EPS:-$0.13
+40.9% YoY
Total Revenue
$130K
Previous year: $148K
-12.2%
Gross Profit
-$10K
Cash and Equivalents
$43M
Previous year: $90.3M
-52.4%
Free Cash Flow
-$10.3M
Total Assets
$81.7M
Previous year: $132M
-38.0%

Ovid Therapeutics

Ovid Therapeutics